Strategic Leadership CenExel has recently expanded its leadership team with a new Chief Financial Officer & Head of Strategy and appointm ents of a CEO, signaling a strategic shift toward strengthened financial discipline, growth initiatives, and broader strategic framing for clinical research operations.

Financial Scale With reported revenue in the 100M to 250M range and a nationwide network of 18 Centers of Excellence, CenExel presents a scale that can attract large pharma and mid to late-stage biotech programs seeking robust site networks for complex trials.

Clinical Reach A nationwide, wholly owned network of 18 Centers of Excellence across major U.S. metros positions CenExel as a turnkey partner for multi-site trials, enabling streamlined site selection, patient engagement, and study close-out across regions.

Clinical Expertise Decades of experience (40+ years) and high-quality data, patient engagement, and operational efficiency provide a compelling value proposition for sponsors pursuing complex trials, real-world solutions, and accelerated timelines.

Talent Momentum Recent hires across finance leadership, principal investigator roles, and clinical science leadership indicate investment in core capabilities and subject-matter depth, suggesting opportunities to upsell specialized trials, investigator-led studies, and expanded scope with large sponsors.